We are building on the successful collaborations we have formed with leading academic research organizations such as the University of Virginia (UVA), Johns Hopkins University (JHU), and government organizations such as the National Cancer Institute’s (NCI) Adult Brain Tumor Consortium (ABTC), and the Office of Naval Research (ONR).

We are currently seeking to develop partnerships with collaborators to explore the many indications that are characterized by hypoxia at the cellular level, especially with those who specialize in the following therapeutic areas:

• Oncology (especially potential Principal Investigators for the Phase 1/2 GBM study)
• Cardiovascular (acute and chronic)
• Respiratory (acute and chronic)
• Emergency medicine/trauma
• Other niche indications

To initiate discussions, please contact Dr. Kim Mays Whitten, PharmD, RAC.